Aflibercept

Results: 25



#Item
1Finley_MSM Consortium Meeting_2013.key

Finley_MSM Consortium Meeting_2013.key

Add to Reading List

Source URL: www.cse-lab.ethz.ch

Language: English - Date: 2015-10-12 08:25:52
2Dow Jones VentureWire Versant-Backed Inception Sciences Creates Eye-Drug Startup With Bayer Healthcare th  November

Dow Jones VentureWire Versant-Backed Inception Sciences Creates Eye-Drug Startup With Bayer Healthcare th November

Add to Reading List

Source URL: www.versantventures.com

Language: English - Date: 2014-01-21 19:48:19
3Published OnlineFirst June 1, 2011; DOI:.CCRMyeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept John F. de Groot, Yuji Piao, Hai Tran, et al. Clin Can

Published OnlineFirst June 1, 2011; DOI:.CCRMyeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept John F. de Groot, Yuji Piao, Hai Tran, et al. Clin Can

Add to Reading List

Source URL: neurooncology.ucla.edu

Language: English - Date: 2011-08-25 12:44:06
    4PRESTATIE- EN TARIEFBESCHIKKING ADD-ON AFLIBERCEPT Nummer  Datum inwerkingtreding

    PRESTATIE- EN TARIEFBESCHIKKING ADD-ON AFLIBERCEPT Nummer Datum inwerkingtreding

    Add to Reading List

    Source URL: www.nza.nl

    Language: Dutch - Date: 2015-03-06 04:23:42
      5September 16, 2014  EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea

      September 16, 2014 EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea

      Add to Reading List

      Source URL: files.shareholder.com

      Language: English
        6Neurotech Announces FDA Acceptance of Investigational New Drug Application and Clinical Trial Initiation of Novel Therapy for Wet AMD Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Stu

        Neurotech Announces FDA Acceptance of Investigational New Drug Application and Clinical Trial Initiation of Novel Therapy for Wet AMD Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Stu

        Add to Reading List

        Source URL: www.neurotechusa.com

        Language: English - Date: 2015-03-30 15:27:53
        7HIGHLIGHTS OF PRESCRIBING INFORMATION  These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Injection For Intra

        HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Injection For Intra

        Add to Reading List

        Source URL: www.regeneron.com

        Language: English - Date: 2015-04-09 21:19:43
        8ZALTRAP® (ziv-aflibercept)

        ZALTRAP® (ziv-aflibercept)

        Add to Reading List

        Source URL: www.regeneron.com

        Language: English - Date: 2014-11-11 09:09:53
        9Ranibizumab / Vascular endothelial growth factor / Bevacizumab / Macular degeneration / Macular edema / Diabetic retinopathy / Laser coagulation / Retina / Low vision / Medicine / Ophthalmology / Vision

        6.2 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®; Bayer Australia Ltd.

        Add to Reading List

        Source URL: www.pbs.gov.au

        Language: English - Date: 2015-03-16 01:05:14
        10Public Summary Document – November 2014 PBAC Meeting  7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial,

        Public Summary Document – November 2014 PBAC Meeting 7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial,

        Add to Reading List

        Source URL: www.pbs.gov.au

        Language: English - Date: 2015-03-16 01:05:14